| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.51 | 0.07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |